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Healthy blood donors from the city of Zagreb were
checked for the presence of a nephrotoxic
mycotoxin ochratoxin A (OTA) in the plasma.
Samples of blood were collected in June,
September, and December 1997, and March
1998, totalling 200 or 50 in each round. The
concentrations of OTA were measured using high
pressure liquid chromatography (HPLC) method
(detection limit 0.2 ng OTA/ml of plasma). The
frequency of OTA-positive samples (>0.2 ng/ml of
plasma) showed significant seasonal variation
(P<0.001). The frequency of OTA-positive
samples was the highest in March (65%) and it
gradually decreased towards December (12%).
The high frequency of positive samples coincided
with seasons favouring growth of moulds and
production of toxins. The daily intake of OTA by
healthy persons in Zagreb was estimated from the
mean concentration of OTA in samples collected
during the whole year (0.19 ng OTA/ml plasma).
The estimated daily intake was 0.26 ng/kg b.w.,
that is, substantially below the tolerable daily
intake proposed by World Health Organization
(16.0 ng/kg b.w.).
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Ochratoxins are the mycotoxins produced by storage moulds of Aspergillus and
Penicillium strains which contaminate cereals, meat, and various other commodities
(1). The most important ochratoxin is the nephrotoxic ochratoxin A (OTA), present in
cereals, meat, coffee, wine, and beer. It is supposed to play a role in the etiology of
endemic nephropathy (2, 3). Its presence was first detected in the blood of inhabit-
ants from an endemic region of Croatia (4). Consequently, it had systematically been
measured in the blood of inhabitants in endemic villages for several years (5, 6). As
a matter of fact, OTA was found in the plasma of inhabitants from endemic and from
control villages, but the concentration of OTA was higher in endemic villages (5–7).
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The high frequency of samples with low concentrations of OTA was found in other
countries where the endemic nephropathy was not detected (8–11). Countries like France,
Switzerland, and Sweden showed regional differences in mean concentrations of OTA
(8, 11, 12) probably as the consequence of different dietary habits in those regions.
The aim of our investigation was to check the frequency and the concentration of
OTA in healthy inhabitants of Zagreb and to compare them with healthy inhabitants of
other countries. The mean concentration of OTA in plasma makes it possible to esti-
mate the daily intake of this toxin and the comparison with recommended limits.
MATERIALS AND METHODS
Chemicals
Crystalline OTA was obtained from Sigma (St. Louis, MO, USA). Acetic acid, hydro-
chloric acid, chloroform, magnesium chloride, and TRIS buffer were obtained from
Kemika (Zagreb, Croatia), and acetonitrile and water, both HPLC-grade, came from
MERCK (Darmstadt, Germany).
Standards
Standard samples with OTA were prepared by adding known amounts of stock solu-
tion (0.1 mg OTA/ml of TRIS, pH 7.4) to portions of pooled plasma.
Plasma samples
Blood samples of healthy volunteers were collected at the Croatian Institute for Trans-
fusion Medicine in Zagreb in the first week of June, September, and December 1997,
and March 1998. Each time 50 samples of about 5 ml of blood were taken. Samples
were centrifuged and the plasma was stored at -80 °C until analysed. The project was
approved by the Ethical Committee of the Croatian Institute for Transfusion Medicine
and the volunteers were informed about its purpose.
Extraction and purification of plasma samples
Plasma samples were extracted and purified using the method described by Beker
and Radi} (13), with 87% recovery of OTA from standards. The evaporated residue
was kept at -20 °C until analysed.
The detection limit of the method was 0.2 ng of OTA/ml plasma. The limit was
calculated as the amount of toxin that gave a peak height three times higher than the
mean noise signal.
High pressure liquid chromatography
Equipment consisted of isocratic pump (Gilson 305), manometer (Gilson 805), injec-
tor (Rheodyne 7125) with loop (50 µl), fluorescent detector (Thermo Separation Prod-
ucts – Spectra System FL 2000) printer (Gilson N1), column, and guard column filled
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with C18 reverse phase (Licrospher, Merck), with dimensions 4.0 x 125.0 mm and
4.0 x 4.0 mm, respectively. The particles of the stationary phase were 5 µm.
Chromatographic conditions
The ratio of acetonitrile:water:acetic acid in the mobile phase was 500:500:5, respec-
tively at pH 3.16. At room temperature the flow rate was 0.5 ml/min and the pressure
22 bars. The wave length of the fluorescent detector was 336 nmλex and 464 nm λem.
The retention time was about nine minutes and the injected volume was 50 µl.
Statistics
Standard curves were calculated from the results of analysis of the spiked plasma
samples using the least-square method. The results of plasma sample analysis were
divided in two groups: below and above the detection limit of 0.2 ng OTA/ml plasma.
The statistical significance of the seasonal variations of OTA-positive samples was
calculated using the χ2-test, and was confirmed through the Fisher’s exact test.
Estimated daily intake of ochratoxin A
The daily intake of OTA was estimated from the mean concentrations of OTA in all
samples collected in one season, using the equation given by Breitholtz and co-
workers (12):
ko=1.34xCp
where ko is the constant of daily intake (ng/kg b.w.) and Cp is the concentration of
OTA in plasma.
RESULTS
Table 1 shows the results of the OTA analysis of plasma samples of healthy blood
donors. OTA-positive samples were found in plasma collected in all seasons. The
analysis of OTA-positive samples was not even throughout the year and the differenc-
es in the frequency of positive samples were significant (P<0.001). Under the null
hypothesis of equal proportions, the frequency of positive samples was lower than
expected in March and higher than expected in December. Only two plasma samples
contained over 1.0 ng/ml OTA, one collected in March (1.2 ng/ml) and the other in
June (1.3 ng/ml).
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Table 2 shows mean concentrations of OTA in all samples from each collection
round. The mean concentration reached the peak in March, after which it kept falling.
The mean concentration in all collected samples is low and so is the calculated daily
intake of OTA for the donors.
Table 2 Seasonal variations in the mean concentration of ochratoxin A in plasma and the estimated
daily intake in Zagreb
Mean concentration Daily intake







Table 1 Seasonal variations in the frequency of ochratoxin A-positive samples in Zagreb
(P>0.001, χ2-test)
Concentration of Number of
OTA (ng/ml) samples
<0.2 >0.2
















Total 110 88 198
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DISCUSSION
The similarity of morphological changes in the kidney of patients with endemic neph-
ropathy and in the kidney of pigs exposed to ochratoxin A in feed in Scandinavia
suggests the possibility that OTA plays a role in the etiology of endemic nephropathy
(2). Inhabitants of endemic villages showed significantly higher blood OTA concentra-
tions than did controls from nonendemic villages (6, 7). However, OTA was often
found in small concentrations in a number of European countries (Table 3). The
Table 3 The frequency of ochratoxin A-positive samples of plasma in inhabitants of European
countries. The mean concentration was calculated in all samples analysed
Collecting OTA positive/ Mean
Country period analysed concentration Range Reference
(%) (ng/ml) (ng/ml) (no.)
Bulgaria 1984 – 1990 9/125 (7) 0.2 (7)
Czechoslovakia 1990 35/143 (24) 0.14 0.1 – 1.3 (14)
Czech Republic 1994 734/809 (91) 0.23 0.1 – 13.7 (15)
1995 404/413 (98) 0.24 0.1 – 1.9 (15)
Denmark 1986 – 1988 78/144 (54) 1.8 0.1 – 13.2 (9)
France 1991 – 1992 (8)
Alsace 97/500 (19) 0.1 – 11.8
Aquitaine 385/2055 (19) 0.1 – 16.0
Rhone-Alpe 75/515 (15) 0.1 – 4.3
Germany 1977 84/164 (51) 0.4 0.1 – 14.4 (16)
1985 89/141 (63) 0.3 0.1 – 1.8 (16)
1988 142/208 (68) 0.75 0.1 – 8.0 (17)
Hungary 1994 52/100 (52) 0.48 (18)
1995 291/355 (82) 0.2 – 10.0 (19)
1997 213/277 (77) 0.1 – 1.4 (20)
Italy 1992 65/65 (100) 0.53 0.1 – 2.0 (10)
1997 87/100 (87) 0.45 (21)
Poland 1983 – 1984 25/397 (6) 0.2 1.0 – 13.0 (22)
1984 – 1985 52/668 (8) 0.3 1.0 – 40.0 (22)
Spain 1996 – 1998 40/75 (53) 0.71 0.5 – 4.0 (23)
Sweden 1989 (12)
Visby 29/99 (29) 0.26 0.3 – 7.0
Uppsala 3/99 (3) 0.02 0.3 – 0.8
Ostersund 6/99 (6) 0.03 0.3 – 0.8
Switzerland 1989 (11)
north of the Alps 251/252 (100) 0.06 – 2.14
south of the Alps 116/116 (100) 0.11 – 6.02
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frequency of OTA-positive samples depends on the sensitivity of the method used. In
Switzerland, OTA was found in all samples of human plasma. The investigation used
a very sensitive HPLC method with immunoaffinity column cleanup (detection limit
0.06 ng OTA/ml plasma) (11). A study in Poland using a spectrofluorimetric method
(detection limit 1.0 ng OTA/ml plasma), however, revealed only 6–8% of OTA-positive
samples (22). As it is difficult to compare the frequency of positive samples, it seems
that the mean concentration in all samples would be a better parameter for the
comparison. In our investigation, the mean OTA concentration in all samples regard-
less of the collection period was 0.19 ng of OTA/ml of plasma. This concentration is
not high and corresponds to the mean concentration of OTA in blood of healthy
inhabitants in other European countries with continental climate (Czech Republic,
Bulgaria, and Poland).
Most similar investigations in European countries do not state the season in
which the samples were collected. Our investigation showed significant seasonal vari-
ations in the frequency of OTA-positive samples in Zagreb;  OTA-positive samples
were the most frequent in March, decreasing gradually towards December. The peri-
od with the highest frequency of OTA-positive samples (and the highest mean con-
centration of OTA) corresponds to the season favouring the growth of moulds and
consequent production of toxin.
The frequency of OTA-positive samples (>0.2 ng/ml plasma) found in Zagreb
did not differ from the frequency in Split, Rijeka, and Vara‘din from our previous
investigation carried out in June (24). However, all samples from Osijek were OTA-
positive, and the mean concentration was 0.68 ng of OTA/ml of plasma. An investi-
gation in France, Switzerland, and Sweden revealed significant regional variations in
the frequency of OTA-positive samples or in the mean concentration of OTA (8, 11,
12). The authors believe that these variations are the consequence of specific dietary
habits in these regions. The same is probably true for the inhabitants of Osijek who
»excel« in consumption and preference of fresh and dried pork over fruit and vegeta-
bles with respect to other inhabitants of Croatia (25).
The daily intake of OTA could be estimated from the OTA concentration in food
or from the OTA concentration in human plasma. Both calculations include some
approximations. The first calculation poses the problem of food sampling. The deter-
mination of OTA in various commodities requires different methods of analysis. This
method of estimation should rely on the analysis of a large number of food samples.
The advantage of the latter method of estimation (from the mean OTA concentration
in population) is that it only needs a proper method of blood analysis. Positive blood
OTA confirms the exposure to this toxin, but it does not indicate the origin of expo-
sure. On the other side, toxicokinetics of OTA in humans is not established and this
calculation should include the approximations from toxicokinetics in monkey. Both
calculations were compared and gave very similar results (26).
Seasonal variations of daily intake of OTA in Zagreb range from 0.11 to 0.36 ng/kg
b.w. The mean daily intake of 0.26 ng OTA/kg b.w. is lower than the mean European
daily intake estimated from the mean blood concentration (0.9 ng/kg b.w.) found in
a large investigation which included 13 European countries (27). The estimated daily
intake of OTA in Zagreb is much below the limit of 16.0 ng/kg b.w. recommended by
World Health Organisation (28).
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Sa‘etak
NALAZ OKRATOKSINA A U PLAZMI ZDRAVIH LJUDI U GRADU
ZAGREBU
Prisutnost okratoksina A (OTA) mjerena je u plazmi zdravog stanovni{tva u Zagrebu. U o‘ujku, lipnju, rujnu i
prosincu skupljeno je po 50 uzoraka krvi. Koncentracija OTA odre|ena je visokotla~nom teku}inskom
kromatografijom uz granicu detekcije od 0.2 ng/ml plazme. U~estalost uzoraka iznad detekcijske granice bila je
razli~ita u razli~itim godi{njim dobima (χ2-test, P<0,001). U~estalost uzoraka s koncentracijom OTA iznad granice
detekcije bila je najve}a u o‘ujku (65%) te je postepeno opadala do prosinca (12%). Najve}i postotak uzoraka s
OTA iznad detekcijske granice uzorkovan je u onim mjesecima koji pogoduju rastu plijesni i sintezi mikotoksina.
Dnevni unos OTA u zdravih stanovnika grada Zagreba procijenjen je iz srednje koncentracije u svim uzorcima
plazme (0,19 ng/ml). Procijenjeni dnevni unos OTA u gradu Zagrebu je 0,26 ng/kg tj. t., odnosno mnogo je manji
od grani~ne vrijednosti od 16,0 ng/kg tj. t. {to ga je predlo‘ila Svjetska zdravstvena organizacija.
Klju~ne rije~i:
endemska nefropatija, mikotoksini, visokotla~na teku}inska kromatografija, zdravi stanovnici
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